Burden trends and risk factors for prostate cancer from 1990 to 2021: a systematic analysis of the Global Burden of Disease Study 2021
Yuan Xu(Harbin Medical University), Mingming Zhang(Harbin Medical University), Yongshuai Jiang(Harbin Medical University), Zhenwei Shang(Harbin Medical University), Hongchao Lv(Harbin Medical University), Songlin Lu(Harbin Medical University), Dihua Yu(The University of Texas MD Anderson Cancer Center), Wenhua Lv(Harbin Medical University), Ruilin Li(Harbin Medical University), Yan Guo(MACOM (United States)), Shuo Bi(Harbin Medical University), Wei She(Harbin Medical University), Chen Zhang(Wenzhou Medical University), Linna Yuan(Harbin Medical University), Mao Ye(Central South University of Forestry and Technology), Ning Wang(Universiti Sains Malaysia), Hongsheng Tian(Harbin Medical University), Yuping Zou(Harbin Medical University), Xuying Guo(Harbin Medical University), Hongmei Sun(Harbin Medical University), Chang Wang(Harbin Medical University)
Cited by 0
Related Papers
PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients
|Cancer Cell|2004|1.9k
PTEN, PIK3CA, p-AKT, and p-p70S6K Status
|American Journal Of Pathology|2010|285
JAK2-binding long noncoding RNA promotes breast cancer brain metastasis
|Journal of Clinical Investigation|2017|231
ErbB2 Increases Vascular Endothelial Growth Factor Protein Synthesis via Activation of Mammalian Target of Rapamycin/p70S6K Leading to Increased Angiogenesis and Spontaneous Metastasis of Human Breast Cancer Cells
|Cancer Research|2006|200
EZH2 engages TGFβ signaling to promote breast cancer bone metastasis via integrin β1-FAK activation
|Nature Communications|2022|190